Skip to content

A comparative study assessing the secondary prevention efficacy between center-based vs. home-based cardiact rehabilitation in patients with cardiovascular diseases

A comparative study assessing the secondary prevention effects between center-based vs. home-based cardiac rehabilitation in patients with LV dysfunction: a prospective randomized, open, parallel, multicenter study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0006385
Enrollment
1040
Registered
2021-07-27
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral, Others : CR will be carried out either in the hospital (center-based CR: CBCR) or at home (home-based CR: HBCR). And for each CR, two types of CR, i.e. exercise-based CR and comprehensive

Sponsors

Ewha Womans University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Male or female patients aged 18-75 who had a history of recent admission in 6 mo for 1) congestive heart failure (LVEF =40%) or 2) acute myocardial infarction with enhanced risk factors (1 =) * enhanced risk factors of MI : DM, history of old myocardial infarction, history of congestive heart failure, old stroke, peripheral artery obstructive disease, Killip calss 2=, left main disease or coronary artery multivessel (2=) disease , LVEF =40%

Exclusion criteria

Exclusion criteria: 1) exercise is impossible or very difficult 2) high risk for exercise: ventricular arrhythmia or hypotension during basical cardiopulmonary exercise test 3) chronic kidney disease stage 4= (eGFR <30 mL/min/1.73m2) 4) active infection 5) active cancer 6) long term treatment of immune-suppresive drugs or steroid 7) congestive heart failure class 4 8) genetic disorder such as familial hypercholesterolemia 9) life expectancy < 2 yr due to accompanied disease 10) pateints already participated in other RCT (randomized controlled trial) study.

Design outcomes

Primary

MeasureTime frame
a composite of total death, sudden cardiac death, nonfatal MI, nonfatal stroke, revascularization [percutaneous coronary intervention, coronary artery bypass graft surgery], hospitalization due to cardiovascular cause, cardiac transplantation

Secondary

MeasureTime frame
compliance, exercise capacity (VO2 max, 6 minute walking test), hospital admission, HRQoL, drug compliance, economical efficiency, diabetic complication

Countries

Korea, Republic of

Contacts

Public ContactSae seul IM

Ewha Womans University Medical Center

dlato@ewhain.net+82-2-2650-5748

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026